Advanced Diagnostic Equipment sp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-04-09
Share capital
4,391,200.00 PLN
Activity description

Advanced Diagnostic Equipment is a company that has developed a breath analysis system used in clinical studies for monitoring metabolic syndrome and measuring total cholesterol levels. They also conduct research on new materials for sensor applications, including gas sensors for NO2 detection. Additionally, they are collaborating on the commercialization of a non-invasive device called Diabetomat for diabetes management.

Registered address
ul. Włodzimierza Tetmajera 79, 31-352 Kraków, Poland
Email
Electronic delivery address
AE:PL-89157-74845-CSFUD-27

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 321 days for 2024).

  • 202501/06/2026
  • 202401/06/2026
  • 202308/04/2024
  • 202226/03/2024
  • 202120/09/2022
  • 202012/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 63%
Top 71%
City · Kraków11,833 / 16,145
Top 73%
Voivodeship · Małopolskie21,071 / 27,724
Top 76%
Country · Poland227,532 / 297,069
Top 77%

Results vs industry

Revenue
This companyUSD 43.17kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD -173.88kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 216.79kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 614.07kMedianUSD 281.58kAverageUSD 8.35m

Industry

Authorized Representatives

Dominik Grochala age 35 – Vice President of the Management Board
Zbigniew Kąkol age 72 – Attorney-in-fact (sole)
Konstanty Waldemar Marszałek age 73 – President

Manner of representation

If a one-person management board is appointed, the sole member of the management board is authorised to make declarations of will on behalf of the company and to represent it externally, independently; if a multi-member management board is appointed, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, is authorised to make declarations of will on behalf of the company and to represent it externally.

Ownership

OwnerSharesShare valueStake
3,976$107,401.409.0545%
6,000$162,074.5513.6637%
14,388$388,654.7832.7655%
14,248$384,873.0432.4467%
Others
5,300$143,165.8612.0696%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-04-27.

  • mBank
    54 1140 1081 0000 4817 2900 1001
  • mBank
    97 1140 1081 0000 4817 2900 1003

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for research and development projects: industrial research
$78,139
Aid for research and development projects: experimental development
$53,543
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$25,040

Competitors

Name
ETG Network sp. z o.o.
HTA Registry sp. z o.o.
CBK Med Clinic sp. z o.o.
Inphocat - Innovative Photocatalytic Solutions sp. z o.o.
What P.S.A.
Zawamed sp. z o.o.
Action Research sp. z o.o.
Just Be Innovative sp. z o.o.
Centrum Badań Klinicznych I Rejestrów sp. z o.o.
Air Abrasion System sp. z o.o.

Change history

DateEvent
2025-07-05Share capital increase
2024-10-24Share capital increase
2024-10-24PKD change
2024-04-09Share capital increase
2024-03-12Address change

FAQ

Last updated: 2026-10-07